Specifically, we used CRISPR to edit the Cx43-Y17 alleles, resulting in the Y17Y synonymous mutation control or the Y17S point mutation in the wild-type (wt) Cx43 alleles of the A549 human lung cancer cell line. The gene discussed is GJA1; the disease is lung cancer.